Navigation Links
Researchers develop world's first biodegradable joint implant
Date:2/28/2012

Tampere University of Technology (TUT), Finland, has been the first in the world to develop biodegradable joint implant, RegJoint. The implant is used in the treatment of osteoarthritis and rheumatoid arthritis.

RegJoint has recently received CE Mark approval that allows the product to be sold in the European Union. The joint implant, which has been developed since the mid-1990s, is the result of collaboration between the Department of Biomedical Engineering at Tampere University of Technology, Conmed Linvatec Biomaterials, Scaffdex Ltd and a group of orthopaedic surgeons, among others, from Tampere University Hospital. Scaffdex Ltd will bring RegJoint to the market.

New treatment for arthritic patients

Rheumatoid arthritis and osteoarthritis destroy the normally smooth cartilage that lines the ends of bones. As cartilage regenerates poorly, the injuries are difficult to treat. Joint injury reduces mobility and causes pain. The conventional surgical options involve permanent implants or the artificial induction of joint ossification between two bones. RegJoint offers an alternative for conventional surgery and has several advantages over permanent implants. For example, the patient's own bone tissue remains intact during the operation. In addition, the implant makes the reconstruction of the joint more sustainable and cushions the area, relieving pain caused by friction between the bones.

The implant is used to repair injuries in the small joints of the fingers and toes. It is made of biodegradable polylactide copolymer and placed inside the joint capsule that surrounds the joint. The implant stimulates the body to produce connective tissue cells and is gradually replaced by the patient's own soft tissue. RegJoint forms a neojoint between the bone ends and restores normal mobility.

The product has undergone extensive clinical trials in Finland and abroad and patients have reported positive results.


'/>"/>

Contact: Minna Kellomki
minna.kellomaki@tut.fi
358-407-066-312
Tampere University of Technology
Source:Eurekalert

Related biology news :

1. Researchers identify novel pathway responsible for infection of a common STD pathogen
2. Researchers discover how vitamin D inhibits inflammation
3. Purdue researchers reveal role of protein mutation in Parkinsons disease
4. UVic researchers among presenters at global science conference
5. Researchers develop better control for DNA-based computations
6. Researchers warn nanoparticles in food, vitamins could harm human health
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Researchers make living model of brain tumor
9. MDC researchers reveal molecular mechanism underlying severe anomalies of the forebrain
10. Grass to gas: UGA researchers genome map speeds biofuel development
11. Researchers develop new method for creating tissue engineering scaffolds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2019)... ... August 15, 2019 , ... Deep Science Ventures (DSV), a new ... a new unit dedicated to building 100 companies over the next 10 years to ... chains. , Deep Science Ventures was founded to create a better method for ...
(Date:8/14/2019)... ... August 14, 2019 , ... Join Jonathan Riek, PhD, ... on Tuesday, September 10, 2019 at 1pm EDT to learn about two common ... management. , NAFLD is the most common diffuse liver disease, with a worldwide ...
(Date:8/9/2019)... ... ... With a demand in healthcare to lower unneeded emergency room visits and provide ... in the coming years, according to a new report on the industry by market ... is a detailed look at the current state of these healthcare outlets, including the ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. ... continually expanding library of more than 20 million articles, sourced from more than ...
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., a full-service early ... that they will be receiving 3 awards at the 2019 CRO Leadership Awards, to ... in the categories of overall Quality and Compatibility (Access to desired markets, cultural fit, ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... applications from the USPTO providing proprietary interest to our methodology, processes, and ... DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep ...
Breaking Biology Technology: